Induction FOLFOX with or without Aflibercept followed by chemoradiation in High Risk Locally Advanced Rectal Cancer. Phase II randomized, multicenter, open label trial.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- Acronyms RIA study
- 02 Feb 2017 Planned End Date changed from 1 Mar 2020 to 1 Feb 2020.
- 02 Feb 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Sep 2017.
- 02 Feb 2017 Status changed from recruiting to active, no longer recruiting.